The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of neutrophil-lymphocyte ratio (NLR) with clinical outcomes in patients (pts) with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with combination of cetuximab and nivolumab (C+N).
 
Robin Park
No Relationships to Disclose
 
Fahad Rind
No Relationships to Disclose
 
Tyler Kristoff
Patents, Royalties, Other Intellectual Property - Provisional Patent: Cathet-HugHER - A Paracentesis Retention Accessory
 
Jiannong Li
No Relationships to Disclose
 
Robbert Slebos
No Relationships to Disclose
 
Sowjanya Thatikonda
No Relationships to Disclose
 
Ritu Chaudhary
No Relationships to Disclose
 
Maria Poole
No Relationships to Disclose
 
David Kaldas
No Relationships to Disclose
 
Joaquim Farinhas
Stock and Other Ownership Interests - Kannact
 
Juan C. Hernandez-Prera
No Relationships to Disclose
 
Kedar Kirtane
Stock and Other Ownership Interests - Agenus; Immunomedics; Macrogenics; Myovant Sciences; Oncternal Therapeutics; Seagen; Veru
Consulting or Advisory Role - MyCareGorithm
 
James William Rocco
Consulting or Advisory Role - Merck
Travel, Accommodations, Expenses - Merck
 
Priyanka Bhateja
No Relationships to Disclose
 
Conor Ernst Steuer
Honoraria - Merck
Consulting or Advisory Role - Abbvie; ARMO BioSciences; BerGenBio; Caris Life Sciences; Lilly; Mirati Therapeutics; Sanofi/Regeneron
Research Funding - Daiichi Sankyo; Infinity Pharmaceuticals; Seagen; Vaccinex
 
Nabil F. Saba
Honoraria - American Journal OF Managed Care; AstraZeneca; Eisai; EMD Serono; Exelixis; GlaxoSmithKline; Inovio Pharmaceuticals; Merck; Novartis; vaccinex
Research Funding - Bristol-Myers Squibb; Exelixis
Patents, Royalties, Other Intellectual Property - Springer textbook Royalty; Uptodate chapter writing and editing
Travel, Accommodations, Expenses - Merck
 
Marcelo Raul Bonomi
Consulting or Advisory Role - Merck
Research Funding - Regeneron (Inst)
 
Christine H. Chung
Consulting or Advisory Role - Brooklyn ImmunoTherapeutics; Exelixis; Fulgent Pharma; Genmab; Merck
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Brooklyn ImmunoTherapeutics (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Merck (Inst); Regeneron (Inst)